-
Holden, SE, Setyawan, J, Coghill, D, Hodgkins, P, Currie, CJ.
1041 – The incidence, resource utilization and financial costs of treating children with attention deficit/hyperactivity disorder (ADHD) in the united kingdom (UK).
European Psychiatry
28:
1
2013
view publication
-
Coghill, D, Banaschewski, T, Lecendreux, M, Soutullo, C, Johnson, M, Zuddas, A, Anderson, C, Civil, R, Higgins, N, Bloomfield, R, et al.
957 – Post hoc comparison of the efficacy of lisdexamfetamine dimesylate and osmotic-release oral system methlyphenidate in children and adolescents with adhd.
European Psychiatry
28:
1
2013
view publication
-
Lecendreux, M, Banaschewski, T, Soutullo, C, Johnson, M, Zuddas, A, Anderson, C, Civil, R, Higgins, N, Bloomfield, R, Squires, L, et al.
958 – Efficacy of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder: effect of age, sex and baseline disease severity.
European Psychiatry
28:
1
2013
view publication
-
Setyawan, J, Banaschewski, T, Hodgkins, P, Lecendreux, M, Johnson, M, Zuddas, A, Bloomfield, R, Coghill, DR.
UT4 Health Utility Scores in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: Response to Stimulant Treatment.
Value in Health
15(7)
:
a284
2012
view publication
-
Coghill, D, Banaschewski, T, Lecendreux, M, Johnson, M, Zuddas, A, Anderson, C, Civil, R, Lyne, A, Gasior, M, Squires, L.
P.7.c.009 Maintenance of efficacy of lisdexamfetamine dimesylate in children and adolescents with ADHD: randomised withdrawal design.
European Neuropsychopharmacology
22:
s431 -s432
2012
view publication